Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 14 M11 M10 M7 M15 M12 M 44 M Research & development —————— — Operating income 148 M155 M155 M156 M166 M173 M 650 M Non-Operating Income, Total 1 M04 M2 M1 M4 M 11 M Interest expense, net of interest capitalized 40 M40 M40 M41 M40 M42 M 163 M Non-Operating Income, excl. Interest Expenses -39 M-40 M-39 M-41 M-39 M-41 M -160 M Unusual income/expense 003 M2 M03 M 8 M Pretax income 146 M145 M153 M154 M170 M169 M 646 M Equity in earnings 37 M30 M34 M138 M43 M33 M 248 M Taxes 35 M34 M35 M40 M36 M53 M 164 M Non-controlling/minority interest 3 M4 M3 M3 M4 M4 M 14 M After tax other income/expense —————— — Net income before discontinued operations 108 M107 M115 M111 M130 M112 M 468 M Discontinued operations —————— — Net income 108 M107 M115 M111 M130 M112 M 468 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 108 M107 M115 M111 M130 M112 M 468 M Basic earnings per share (Basic EPS) 1.071.051.141.081.281.1 4.6 Diluted earnings per share (Diluted EPS) 1.061.041.131.071.271.09 4.56 Average basic shares outstanding 101.4 M101.6 M101.6 M101.6 M101.8 M102 M — Diluted shares outstanding 102.5 M102.5 M102.5 M102.5 M102.7 M102.6 M — EBITDA ———320 M—— — EBIT 148 M155 M155 M243 M167 M264 M 829 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) ———77 M—— —